Oviduct patency control by means of 133Xe-solution.

Nuclear-Medizin Pub Date : 1976-02-01

T Pertyński, W Radecki, J Bialobrzeski

引用次数: 0

Abstract

The authors describe a radioisotopic method for the oviduct patency control in patients suffering from primary or secondary sterility. The application of 133Xe causes at least about 3-4 times less radiation than hysterosalpingographical tests. Ease of interpretation facility, painlessness and comparability of the results were noticed.

本刊更多论文

133xe溶液控制输卵管通畅。

作者描述了一种用于原发性或继发性不孕症患者输卵管通畅控制的放射性同位素方法。应用133Xe引起的辐射至少比子宫输卵管造影检查少3-4倍。判读方便，无痛，结果具有可比性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nuclear-Medizin

自引率

0.00%

发文量